Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLS-005 (Trehalose) in ALS (HEALEY Platform Regimen E)
NCT05136885Phase 3Completed
- Start
- Feb 2022
- Primary completion
- Aug 2023
- Modality
- Drug Delivery Systems, DNA Intercalators/Alkylators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of trehalose in amyotrophic lateral sclerosis (ALS). Started Feb 2022; status: completed.
02
Drugs
trehalose
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT05136885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136885.